1. Parkin DM, Muir CS, Whelan SL ve ark. Cancer incidence in five continents. Lyon, IARC Scientific Publications 1992; 770-3.
2. Whittemore AS, Harris R, Itnyre J. The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136(10): 1204-11.
3. Mant JWF, Vessey MP. Ovarian and endometrial cancers. Trends in Cancer'de. Ed. Doll R, Fraumeni JF Jr, Muir CS. Incidence and Mortality. Plainview. Cold Spring Harbor Laboratory Press 1994: 287-307.
4. Buell P, Dunn JE. Cancer mortality among Japanese Isseri and Niseri of California. Cancer 1965; 18: 656-64.
5. Kliewer EV, Smith KR. Ovarian cancer mortality among immigrants in Australia and Canada. Cancer Epidemiol Biomarkers Prev 1995; 4(5):
453-8.
6. Booth M, Beral V. The epidemiology of ovarian cancer. Ovarian Cancer'de. Ed. Hudson CN. Oxford, Oxford University Press 1985; 22-44.
7. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990; 132(3): 446-52.
8. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988; 42(5): 690-6.
9. Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer 1993; 71(2 Suppl): 566-72.
10. Friedman LS, Ostermeyer EA, Lynch ED. The search for BRCA1. Cancer Res 1994; 54(24): 6374-82.
11. Gayther SA, Mangion J, Russell P ve ark. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA 2 gene. Nat Genet 1997; 15(1): 103-5.
1 2. Koch M, Gaedke H, Jenkins H. Family history of ovarian cancer pati¬ents: a case-control study. Int J Epidemiol 1989; 18(4): 782-5.
13. Franceschi S, La Vecchia C, Mangioni C. Familial ovarian cancer: eight more families. Gynecol Oncol 1982; 13(1): 31-6.
14. Lurian JR, Piver MS. Familial ovarian cancer. Gynecol Oncol 1979;
8(2): 185-92.
15. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrojen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141(9): 828-35.
16. Purdie D, Green A, Bain C ve ark. Reproductive and other factors and risk of epithelial ovarian cancer. Int J Cancer 1995; 62(6): 678-84.
17. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140(7): 585¬97.
18. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Case control study of borderline ovarian tumours: reproductive history and exposure to exo¬genous female hormones. Cancer Res 1988; 48(20): 5849-52.
19. Franceschi S, La Vecchia C, Booth M ve ark. Pooled analysis of 3 Eu¬ropean case-control stuties of ovarian cancer: II. Age at menarche and at
menopause. Int J Cancer1991; 49(1): 57-60.
20. Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE. Oral cont¬raceptives and risk of ovarian cancer. Cancer 1981; 48(7): 1684-7.
21. Annegers JF, Strom H, Decker DG, Dockerty MB, O'Fallon WM.
Ovarian cancer: incidence and case-control study. Cancer 1979; 43(2):
723-9.
22. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Deve¬lopment. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987; 316(11): 650-5.
23. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of
ovarian cancer in relation to the use of oral contraceptives. Int J Cancer
1981; 28(6): 669-71.
24. Brinton LA, Melton LJ 3rd, Malkasian GD Jr, Bond A, Hoover R.
Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129(4):
712-22.
25. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tu¬mors in a cohort of infertile women. N Engl J Med 1994; 331(12): 771-6.
26. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet
1995; 346(8981): 995-1000.
Thank you for copying data from http://www.arastirmax.com
